Processa Pharmaceuticals (PCSA) Current Taxes (2012 - 2017)
Processa Pharmaceuticals' (PCSA) quarterly Current Taxes came in at $200.0 in Q2 2017, little changed YoY from $200.0 in Q2 2016, and little changed on a QoQ basis from $200.0 in Q1 2017.
Processa Pharmaceuticals (PCSA) Current Taxes (2012 - 2017) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 6 years of Current Taxes data on file, last reported at $200.0 in Q2 2017.
- Quarterly Current Taxes changed 0.0% year-over-year to $200.0 in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $200.0 (changed 0.0% YoY) and the FY2016 annual result came in at $200.0, changed 0.0% from the prior year.
- Current Taxes was little changed at $200.0 in Q2 2017, from $200.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $200.0 in Q4 2015 to a low of $50.0 in Q2 2013.
- A 5-year average of $155.36 and a median of $187.5 in 2015 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2013 — Current Taxes sank 33.33% — and 2015, when it surged 100.0%.
- Tracing PCSA's Current Taxes over 5 years: stood at $100.0 in 2013, then changed by 0.0% to $100.0 in 2014, then surged by 100.0% to $200.0 in 2015, then changed by 0.0% to $200.0 in 2016, then changed by 0.0% to $200.0 in 2017.
- The last three Current Taxes figures came in at $200.0 (Q2 2017), $200.0 (Q1 2017), and $200.0 (Q4 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Processa Pharmaceuticals | 5.69 Mn | 5.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 200.00 |
| Mar 31, 2017 | 200.00 |
| Dec 31, 2016 | 200.00 |
| Sep 30, 2016 | 200.00 |
| Jun 30, 2016 | 200.00 |
| Mar 31, 2016 | 200.00 |
| Dec 31, 2015 | 200.00 |
| Sep 30, 2015 | 175.00 |
| Jun 30, 2015 | 150.00 |
| Mar 31, 2015 | 125.00 |
| Dec 31, 2014 | 100.00 |
| Dec 31, 2013 | 100.00 |
| Sep 30, 2013 | 75.00 |
| Jun 30, 2013 | 50.00 |
| Dec 31, 2012 | 150.00 |